Chronic Hepatitis Delta

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-05-23
Clinical Trial Update: Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis [Phase 2]
This Phase 2 trial evaluating peginterferon lambda and lonafarnib boosted with ritonavir for chronic Hepatitis Delta has been withdrawn.